The FDA has approved an autoinjector device for Teva Pharmaceutical Industries’ (NYSE:TEVA) migraine med Ajovy (fremanezumab-vfrm). Market launch will commence in the coming months.
https://seekingalpha.com/news/3535397-fda-oks-teva-autoinjector-for-ajovy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.